You are here: Home > Institute of Excellence (CPD) > CPD Events > North Queensland Eye Health Seminar

North Queensland Eye Health Seminar

Date: 10/08/2025 (AEST)

Venue: Rydges Southbank, 23 Palmer St, South Townsville, QLD, 4810

Provider: NQ Eye Foundation

Contact: Todd Goodwin, [E] admin@nqeyespecialists.com.au, [P] 1300856074

Activity Outline

North Queensland Eye Health Seminar is a full day of innovated learning with a focus on the advances in diagnosis, and management, of eye health. The 2025 seminar will focus on two topics: The Eye in MS & Related Demyelinating Disorders and The Diabetic Eye. 

Learning Objectives

  • Outline the potential of AI and big data to transform how we can use "traditional" examinations to look beyond our current understanding of disease.
  • Differentiate between the different forms of demyelinating conditions and their appropriate imaging investigations.
  • Diagnose optic neuritis, distinguish the different subtypes of optic neuritis, determine the urgency, management and describe the prognostic implications of the diagnosis of optic neuritis
  • Describe the risk factors for the development and progression of diabetic retinopathy, assess when diabetic retinopathy requires treatment, and outline what treatments are
  • Describe the mechanism of action of new anti-diabetic drugs and assess the possible effects they can have on patients' ocular health
  • Compare various ocular presentations in multiple sclerosis and other related autoimmune commotions such as NMO and MOGAD and discuss the differentiating features of these conditions.
  • Engage in a two-way, interactive Q&A with the panel of presenters to gain deeper insight into the session’s topic.
  • Describe the current approach to management of acute demyelinating events, as they relate to vision, and summarise the role of disease modifying therapy in MS.
  • Describe the role of the primary care physician, discuss with patients about the addition of diabetic medications for non-glycaemic benefits, and assess patients that would likely not be suitable for these adjuvant medications

Max CPD hours awarded: 6.75

Session Information

Name
Update on Radiological Findings in MS/Demyelination
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
Ocular Manifestations in Multiple Sclerosis and Other Related Autoimmune Conditions
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
0.75
Name
Optic Neuritis - Diagnosis and Management
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
0.75
Name
The Eye in MS and Related Demyelinating Disorders - Q&A Panel/Discussion
Clinical?
Yes
Interactive?
Yes
Therapeutic?
Yes
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
It's Not All About Sugar!
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
0.75
Name
Beyond the DR Eye Examination
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
0.75
Name
Alphabet Soup: The Effect of New Anti-Diabetic Drugs on the Eyes
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
0.75
Name
Diabetic Retinopathy - An Overview
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
0.75
Name
The Diabetic Eye - Q&A Panel/Discussion
Clinical?
Yes
Interactive?
Yes
Therapeutic?
Yes
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
An Update on Multiple Sclerosis
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
0.75

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.